AIM ImmunoTech Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.19 | $130.51 | 9.00% | 11 | $332.28B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | £165.99 | 34.64% | 16 | £187.73B |
| NOVN | Novartis | Hold |
10
|
CHF93.37 | CHF105.00 | 15.26% | 9 | CHF190.51B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
| GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.39B |
| BAX | Baxter International Inc | Hold |
17
|
$35.25 | $44.86 | 24.82% | 5 | $17.96B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$131.38 | $158.66 | 26.35% | 6 | $12.51B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$29.83 | $44.75 | 34.09% | 0 | $4.19B |
| MDG1 | Medigene | Buy |
6
|
1.41€ | 2.68€ | 90.07% | 0 | 37.46€M |